Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer-Reference-Cited by-同舟云学术

Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer

Published:2018-09 Issue:5 Volume:122 Page:885-889
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Bergamini Corinna,Benfari Giovanni^ORCID,Dolci Giulia,Torelli Flavia,Ghiselli Luca,Trevisani Laura,Truong Stella,Vinco Giulia,La Russa Francesca,Golia Giorgio,Molino Annamaria,Rossi Andrea,Ribichini Flavio L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

2. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems;Bird;Clin Cancer Res,2008

3. Left atrial volume: a powerful predictor of survival after acute myocardial infarction;Moller;Circulation,2003

4. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study;Lonborg;Eur Heart J Cardiovasc Imaging,2013

5. Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure);Rossi;Eur J Heart Fail,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab;Cardiovascular Toxicology;2024-05-02

2. Echocardiographic Assessment of Left Ventricular Function in Three Oncologic Therapeutic Modalities in Women with Breast Cancer: The ONCO-ECHO Multicenter Study;Journal of Clinical Medicine;2024-04-26

3. Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis;Revista Portuguesa de Cardiologia;2023-12

4. Left Atrial Volume Index, Other Systolic and Diastolic Transthoracic Echocardiographic Parameters as Early Predictors for Asymptomatic Trastuzumab Target Cancer Therapy-Related Cardiac Dysfunction among HER2-Positive Breast Cancer Patients at a Tertiary Medical Center in Metro Manila – a Single-Center Prospective Cohort Study;2023-07-25

5. Evaluation of left atrial remodeling using cardiovascular magnetic resonance imaging in breast cancer patients treated with adjuvant trastuzumab;European Radiology;2022-01-06